At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.
Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.
Call for Posters and Flash Presentations
Anyone wishing to present a poster should submit a one-page abstract to email@example.com by Friday 10 September 2021 with "AM-III – poster abstract" in the subject line. Selected poster presenters will have the opportunity to give a flash presentation.
Confirmed speakers and sessions:
Addressing unusual anti-infective targets, Professor Anna Hirsch, Helmholtz Institute of Pharmaceutical Research, Saarland, Germany
Discovery of ETX0462, a novel non-beta-lactam PBP inhibitor to treat Gram-negative infections, including MDR Pseudomonas aeruginosa, Dr Thomas Durand-Reville, Entasis Therapeutics, MA, USA
The truth is out there: Nature as a source of new antimicrobials and alternatives, Prof Gerry Wright, McMaster University, Canada
Tethered macrocyclic peptides, a novel antibiotic class targeting Acinetobacter baumannii, Dr Patrizio Mattei, McMaster University, Canada
More speakers will be announced in due course.
Tel: +44 (0)20 7598 1561